When it comes to treating cancer, doctors are looking for drugs that target specific molecular pathways and halt cell proliferation. A drug called fenbendazole appears to alter several of these pathways, making it a potentially promising cancer treatment. But it’s not yet clear whether the drug actually works in humans.
A study published in the journal Scientific Reports showed that fenbendazole could inhibit the growth of human pancreatic cancer cells in petri dishes and mice. The drug does this by disrupting the cellular process that both viruses and some cancers use to grow and spread.
Several studies have also found that fenbendazole can reduce the growth of lung cancer cells in mice. The drug works by inhibiting the formation of tubulin polymers, which are part of the cytoskeleton that gives shape and structure to cells. It’s similar to the way that anti-cancer drugs like vinca alkaloids (vinblastine, vincristine) and paclitaxel act on microtubules to kill tumor cells.
We surveyed 21 patients who were diagnosed with lung cancer using a semi-structured questionnaire that asked about the acquisition channel of general cancer and false information, the quality of obtained information, and their perception toward it. Participants were ages 56 to 75 and currently in stages one, three, and four of their cancer diagnosis. Interviewees were given a copy of the YouTube video by Joe Tippens, who claimed that taking fenbendazole led to his remission from nonsmall-cell lung cancer. They were also told that he was receiving conventional cancer treatments at the time, and so it’s impossible to attribute his remission to fenbendazole alone. fenbendazole for humans cancer